TW200630358A - Novel product, process and intermediates for preparing azetiding derivatives - Google Patents

Novel product, process and intermediates for preparing azetiding derivatives

Info

Publication number
TW200630358A
TW200630358A TW094135607A TW94135607A TW200630358A TW 200630358 A TW200630358 A TW 200630358A TW 094135607 A TW094135607 A TW 094135607A TW 94135607 A TW94135607 A TW 94135607A TW 200630358 A TW200630358 A TW 200630358A
Authority
TW
Taiwan
Prior art keywords
preparing
derivatives
azetiding
intermediates
novel product
Prior art date
Application number
TW094135607A
Other languages
English (en)
Inventor
Stephane Mutti
Michel Lavigne
Luc Grondard
Joel Malpart
Joerg Rieke-Zapp
Veronique Crocq-Stuerga
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of TW200630358A publication Critical patent/TW200630358A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW094135607A 2004-10-14 2005-10-13 Novel product, process and intermediates for preparing azetiding derivatives TW200630358A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0410844A FR2876688B1 (fr) 2004-10-14 2004-10-14 Nouveau produit, procede et intermediaires de preparation de derives d'azetidine

Publications (1)

Publication Number Publication Date
TW200630358A true TW200630358A (en) 2006-09-01

Family

ID=34954419

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094135607A TW200630358A (en) 2004-10-14 2005-10-13 Novel product, process and intermediates for preparing azetiding derivatives

Country Status (21)

Country Link
US (1) US7687493B2 (zh)
EP (1) EP1805167A2 (zh)
JP (1) JP2008516932A (zh)
KR (1) KR20070063544A (zh)
CN (1) CN101039931A (zh)
AR (1) AR051390A1 (zh)
AU (1) AU2005293454A1 (zh)
BR (1) BRPI0516507A (zh)
CA (1) CA2583992A1 (zh)
EA (1) EA011408B1 (zh)
EC (1) ECSP077332A (zh)
FR (1) FR2876688B1 (zh)
IL (1) IL181904A0 (zh)
MA (1) MA29513B1 (zh)
MX (1) MX2007003923A (zh)
NO (1) NO20072192L (zh)
SG (1) SG155193A1 (zh)
TN (1) TNSN07097A1 (zh)
TW (1) TW200630358A (zh)
WO (1) WO2006040465A2 (zh)
ZA (1) ZA200702528B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113045539B (zh) * 2021-03-30 2021-12-07 苏州大学 2-(4,4-二氯-1-(8-喹啉基)-2-氮杂环丁基)羧酸酯衍生物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8709887D0 (en) * 1987-04-27 1987-06-03 Univ Alberta Alkyl azodicarboxylates
US5530134A (en) * 1994-09-06 1996-06-25 Synphar Laboratories Inc. Synthesis of anabaseine, salts and derivatives thereof
US6355631B1 (en) * 2000-03-03 2002-03-12 Aventis Pharma S.A. Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and their preparation
FR2805817B1 (fr) * 2000-03-03 2002-04-26 Aventis Pharma Sa Compositions pharmaceutiques contenant des derives d'azetidine, les nouveaux derives d'azetidine et leur preparation
BRPI0113146B8 (pt) * 2000-08-10 2021-05-25 Mitsubishi Pharma Corp "derivados de prolina e composição farmacêutica que os compreende".
CN1874991A (zh) * 2003-08-29 2006-12-06 小野药品工业株式会社 能够结合s1p受体的化合物及其药物用途

Also Published As

Publication number Publication date
EA011408B1 (ru) 2009-02-27
MX2007003923A (es) 2007-06-07
SG155193A1 (en) 2009-09-30
KR20070063544A (ko) 2007-06-19
EA200700840A1 (ru) 2007-08-31
ZA200702528B (en) 2008-07-30
FR2876688A1 (fr) 2006-04-21
AR051390A1 (es) 2007-01-10
MA29513B1 (fr) 2008-06-02
ECSP077332A (es) 2007-04-26
TNSN07097A1 (fr) 2008-06-02
AU2005293454A1 (en) 2006-04-20
US20070270463A1 (en) 2007-11-22
WO2006040465A2 (fr) 2006-04-20
IL181904A0 (en) 2007-07-04
CN101039931A (zh) 2007-09-19
BRPI0516507A (pt) 2008-09-16
US7687493B2 (en) 2010-03-30
FR2876688B1 (fr) 2007-03-16
CA2583992A1 (fr) 2006-04-20
JP2008516932A (ja) 2008-05-22
WO2006040465A3 (fr) 2006-08-10
NO20072192L (no) 2007-04-27
EP1805167A2 (fr) 2007-07-11

Similar Documents

Publication Publication Date Title
MXPA05012362A (es) Yodopirazolilcarboxanilidas.
TW200604179A (en) Pyrazole derivatives, compositions containing such compounds and methods of use
TNSN06409A1 (en) Novel fluoroglycoside derivatives of pyrazoles, medicaments containing these compounds, and the use thereof
DE602005012634D1 (en) Arylsulfonylnaphthalinderivate als 5ht2a-antagonisten
MY145069A (en) Synthesis of acylaminoalkenylene amides useful as substance p antagonists
HUP0501016A2 (en) (s)-4-amino-5-chloro-2-methoxy-n-{1-[1-(2-tetrahydrofurylcarbonyl)-4-piperidinylmethyl]-4-piperidinyl}benzamide, process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
MY140739A (en) 2, 6-quinolinyl derivatives, processes for preparing them and their uses
TWI268278B (en) 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses
IL213799A0 (en) Process for preparing 2,3-disubstituted indoles
TW200745039A (en) Isotopically substituted pantoprazole
MXPA05011962A (es) Oxiarenos substituidos.
HK1086008A1 (en) Process for preparing substituted 5-amino-pyrazolo-Ä4,3-eÜ-1,2,4-triazoloÄ1,5-cÜpyrimidines
TW200730521A (en) Triazine compounds having amino-and carboxyl-containing substituents
TW200503619A (en) Use of isoindolinone derivatives as insecticides
ATE418530T1 (de) Kompaktiertes menthol
TW200626542A (en) Novel process and intermediates for preparing n-(1-benzhydrylazetidin-3-yl)-n-phenylmethylsulfonamide derivatives
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
MXPA05005761A (es) Proceso para preparar (s)-pantoprazola.
TW200630358A (en) Novel product, process and intermediates for preparing azetiding derivatives
IL158998A0 (en) Process for the production of 4-amino-2, 5-bisheterocyclylquinazolines
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
TW200626555A (en) A process for the preparation of 1, 3, 5-trisubstituted pyrazoles via [3+2] cycloaddition
AU2003235814A8 (en) Novel process for the preparation of trans-3- ethyl-2,5- dihydro-4- methyl-n-(2-( 4-(((((4-methyl cyclohexyl) amino)carbonyl) amino)sulfonyl) phenyl)ethyl) -2-oxo-1h-pyrrole -1-carboxamide
MXPA05013034A (es) N-alquinil-2-heteroariloxialquilamidas para uso como fungicidas.
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine